trastuzumab (brand name: Herceptin)

Page last modified on: June 11, 2008
(trass-TOO-zoo-mab)

A drug used to treat women with breast cancer that has too many HER2 genes, or too much HER2 protein. (This type of breast cancer is called HER2-positive.) It is available for women with advanced disease. It may be offered on a clinical trial to women with large cancer or cancer in the lymph nodes. The FISH and IHC tests can show if a cancer is likely to respond to this drug.

Audio contributed by: Olivia Newton-John

Browse Dictionary Alphabetically

Audio Contributors

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. 123
Back to top

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

Learn more about our commmitment to your privacy

© 2008 Breastcancer.org - All rights reserved.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.